1. Wilson KC, Raghu G. The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF. Eur Respir J, 2015, 46(4): 883-886.
[2]
2. Xueli Nan, Chao Xie, Xueyan Yu, Jie Liu.EGFR-TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer. Oncotarget, 2017, 8(43): 75712-75726.
[3]
3. William DH, Cynthia D, Machiko I, et al. EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-αinduced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2008, 294(6): L1217-L1225.
[4]
4. Yoshiki Ishii, Sakae Fujimoto, Takeshi Fukuda. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am J Respir Crit Care Med, 2006, 174(5): 550-556.
6. Canady J, Arndt S, Karrer S, et al. Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J Invest Dermatol, 2013, 133(3): 647-657.
[7]
7. Hoermann G, Cerny-Reiterer S, Herrmann H, et al. Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms. FASEB J, 2012, 26(2): 894-906.
[8]
8. Pollack V, Sark？zi R, Banki Z, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am J Physiol Renal Physiol, 2007, 293(5): F1714-F1726.
[9]
9. Grant SL, Hammacher A, Douglas AM, et al. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Oncogene, 2002, 21(3): 460-474.
[10]
10. Vlaicu P, Mertins P, Mayr T, et al. Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator. BMC Cancer, 2013, 13: 197-209.
[11]
11. Mikawa K, Nishina K, Takao Y, et al. ONO-1714, a nitric oxide synthase inhibitor,attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg, 2003, 97(6):1751-1755.
[12]
12. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol, 1998, 41(4):467-470.
[13]
13. Yan L, Song F, Li H, et al. Submicron emulsion of cinnamaldehyde ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibition of inflammation, oxidative stress and epithelial-mesenchymal transition. Biomed Pharmacother, 2018, 102: 765-771.
16. Nagahama KY, Togo S, Holz O, et al. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3. Am J Respir Cell Mol Biol, 2013, 49(4): 582-591.
[17]
17. Jahani-Asl A, Yin H, Soleimani VD, et al. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci, 2016, 19(6): 798-806.
[18]
18. Guerriero ML, Dudka A, Underhill-Day N, et al. Narrative-based computational modelling of the Gp130/JAK/STAT signalling pathway. BMC Syst Biol, 2009, 3: 40-51.
